年別の研究成果
年別の研究成果
検索結果
-
2022
Corrigendum to ‘Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study’: [ESMO Open Volume 6, Issue 4, August 2021, 100191] (ESMO Open (2021) 6(4), (S2059702921001526), (10.1016/j.esmoop.2021.100191))
Hotta, K., Saeki, S., Yamaguchi, M., Harada, D., Bessho, A., Tanaka, K., Inoue, K., Gemba, K., Shiojiri, M., Kato, Y., Ninomiya, T., Kubo, T., Kishimoto, J., Shioyama, Y., Katsui, K., Sasaki, J., Kiura, K. & Sugio, K., 8月 2022, In: ESMO Open. 7, 4, 100532.研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読
Open Access -
2011
Erratum: Design and rationale of japanese evaluation between formula of azelnidipine and amlodipine add on olmesartan to get antialbuminuric effect study (J-FLAG) : Ion of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria (Cardiovascular Drugs and Therapy (2011) 25 (365366) DOI 10.1007/s10557-011-6309-5))
Ando, K., Haneda, M., Ito, S., Kashihara, N., Node, K., Nangaku, M., Shimosawa, T., Kishimoto, J. & Fujita, T., 8月 2011, In: Cardiovascular Drugs and Therapy. 25, 4, p. 365-366 2 p.研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読
Open Access